相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine
Paul A. Kristiansen et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Nasopharyngeal Colonization by Neisseria lactamica and Induction of Protective Immunity against Neisseria meningitidis
Cariad M. Evans et al.
CLINICAL INFECTIOUS DISEASES (2011)
Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1
Brunella Brunelli et al.
VACCINE (2011)
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
P. B. Keiser et al.
VACCINE (2011)
Independent evolution of the core and accessory gene sets in the genus Neisseria: insights gained from the genome of Neisseria lactamica isolate 020-06
Julia S. Bennett et al.
BMC GENOMICS (2010)
Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine
Ray Borrow et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults
Pablo Bonvehi et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Impact of a Pneumococcal Conjugate Vaccination Program on Carriage among Children in Norway
Didrik F. Vestrheim et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity
Helen Campbell et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998-2007: Implications for Prevention of Meningococcal Disease
Amanda C. Cohn et al.
CLINICAL INFECTIOUS DISEASES (2010)
Multicenter, Open-Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
Jamie Findlow et al.
CLINICAL INFECTIOUS DISEASES (2010)
Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary-School Children in 1999-2000 and Response to a Booster: A Phase 4 Clinical Trial
K. P. Perrett et al.
CLINICAL INFECTIOUS DISEASES (2010)
Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine
Xilian Bai et al.
EXPERT REVIEW OF VACCINES (2010)
Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2, 3, 4 months schedule with a fourth dose at 12-18 months of age
Pirmin Habermehl et al.
HUMAN VACCINES (2010)
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications
Alexander Laarman et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
CURRENT CONCEPTS Advances in the Development of Vaccines against Neisseria meningitidis
Lionel K. K. Tan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age A Double-blind Randomized Active-controlled Trial
Matthew D. Snape et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
John Donnelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates
Rolando Pajon et al.
VACCINE (2010)
A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA
Paul B. Keiser et al.
VACCINE (2010)
Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriage
Dlawer A. A. Ala'Aldeen et al.
VACCINE (2010)
Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine
Wendell D. Zollinger et al.
VACCINE (2010)
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
Han-Qing Jiang et al.
VACCINE (2010)
An Outer Membrane Receptor of Neisseria meningitidis Involved in Zinc Acquisition with Vaccine Potential
Michiel Stork et al.
PLOS PATHOGENS (2010)
The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to Complement
Lisa A. Lewis et al.
PLOS PATHOGENS (2010)
Neisseria meningitidis Opc invasin binds to the cytoskeletal protein α-actinin
Claudia Sa E. Cunha et al.
CELLULAR MICROBIOLOGY (2009)
Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles
Andrew R. Gorringe et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
Caroline L. Trotter et al.
EXPERT REVIEW OF VACCINES (2009)
Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response
V. Weynants et al.
INFECTION AND IMMUNITY (2009)
Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales
Jay Lucidarme et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B Neisseria meningitidis
Ellen Murphy et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Pathogenic neisseriae: surface modulation, pathogenesis and infection control
Mumtaz Virji
NATURE REVIEWS MICROBIOLOGY (2009)
Brief Report: Emergence of Ciprofloxacin-Resistant Neisseria meningitidis in North America.
Henry M. Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine
Sharon H. Wong et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Outcomes of Meningococcal Disease in Adolescence: Prospective, Matched-Cohort Study
Jennie Borg et al.
PEDIATRICS (2009)
Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa
Brown J. Okoko et al.
VACCINE (2009)
Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution
F. Marc LaForce et al.
VACCINE (2009)
Meningococcal carriage and disease-Population biology and evolution
Dominique A. Caugant et al.
VACCINE (2009)
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
Johan Holst et al.
VACCINE (2009)
Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis
Paul B. Keiser et al.
VACCINE (2009)
Seroprevalence of antibodies against fHbp and NadA, two potential vaccine antigens for Neisseria meningitidis
Susanne Jacobsson et al.
VACCINE (2009)
Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease
Susanne Jacobsson et al.
VACCINE (2009)
Meningococcal C conjugate vaccine: The experience in England and Wales
Helen Campbell et al.
VACCINE (2009)
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide
Lisa K. McNeil et al.
VACCINE (2009)
Global epidemiology of meningococcal disease
Lee H. Harrison et al.
VACCINE (2009)
Epidemiology of the Meningococcal Disease in Catalonia before and after Vaccination against Serogroup C
Ana I. Martinez et al.
REVISTA ESPANOLA DE SALUD PUBLICA (2009)
Distribution of transferrin binding protein B gene (tbpB) variants among Neisseria species
Odile B. Harrison et al.
BMC MICROBIOLOGY (2008)
Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci
Gunnstein Norheim et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Longitudinal study of meningococcal carrier rates in teenagers
I. C. Glitza et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2008)
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
Martin C. J. Maiden et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern Ghana
Abraham Hodgson et al.
PLOS ONE (2008)
Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: Implications for introducing PorA based vaccines
David Pace et al.
VACCINE (2008)
Meningococcal carriage in the African meningitis belt
Caroline L. Trotter et al.
LANCET INFECTIOUS DISEASES (2007)
Lack of association between group B meningococcal disease and autoimmune disease
Michael Howitz et al.
CLINICAL INFECTIOUS DISEASES (2007)
Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis
Vincent E. Weynants et al.
INFECTION AND IMMUNITY (2007)
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults
Nilima Kshirsagar et al.
VACCINE (2007)
Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany:: Frequencies and mechanisms
Heike Claus et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Scale-up for bulk production of vaccine against meningococcal disease
Gino J. E. Baart et al.
VACCINE (2007)
Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates
Jane W. Marsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs
Germie P. J. M. van den Dobbelsteen et al.
VACCINE (2007)
Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults
Scott A. Halperin et al.
VACCINE (2007)
Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region
Jeroen Kortekaas et al.
VACCINE (2007)
Immunogenicity and safety of three doses of a bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents
Dominique Boutriau et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales
Caroline L. Trotter et al.
LANCET INFECTIOUS DISEASES (2006)
A review of vaccine research and development: Meningococcal disease
Marc P. Girard et al.
VACCINE (2006)
Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB
A Pettersson et al.
VACCINE (2006)
The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB
DR Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands
SC de Greeff et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Prospects for vaccine prevention of meningococcal infection
LH Harrison
CLINICAL MICROBIOLOGY REVIEWS (2006)
Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: Developmental chemistry and investigation of immunological responses following immunization of mice and rabbits
AD Cox et al.
VACCINE (2005)
Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain
A Larrauri et al.
VACCINE (2005)
Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination
CL Trotter et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Genetic analysis of meningococci carried by children and young adults
H Claus et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Meningococcal surrogates of protection - serum bactericidal antibody activity
R Borrow et al.
VACCINE (2005)
The concept of tailor-made, protein-based, outer membrane vesicle vaccines against meningococcal disease
J Holst et al.
VACCINE (2005)
MeNZB™:: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
P Oster et al.
VACCINE (2005)
Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells
B Capecchi et al.
MOLECULAR MICROBIOLOGY (2005)
Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
LD Fletcher et al.
INFECTION AND IMMUNITY (2004)
Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers
J Bruge et al.
VACCINE (2004)
Neisseria meningitidis:: an overview of the carriage state
SP Yazdankhah et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)
Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine
P De Wals et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
NadA diversity and carriage in Neisseria meningitidis
M Comanducci et al.
INFECTION AND IMMUNITY (2004)
Role of transferrin receptor from a Neisseria meningitidis tbpB isotype II strain in human transferrin binding and virulence
G Renauld-Mongénie et al.
INFECTION AND IMMUNITY (2004)
Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease
DJ Litt et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Distribution of surface protein variants among hyperinvasive meningococci: Implications for vaccine design
R Urwin et al.
INFECTION AND IMMUNITY (2004)
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component
EAL Thompson et al.
MICROBIOLOGY-SGM (2003)
Pathophysiology of meningococcal meningitis and septicaemia
N Pathan et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
V Masignani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Effectiveness of meningococcal C conjugate vaccine in teenagers in England
A Bose et al.
LANCET (2003)
Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998
JF Brundage et al.
CLINICAL INFECTIOUS DISEASES (2002)
NadA, a novel vaccine candidate of Neisseria meningitidis
M Comanducci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination
MCJ Maiden et al.
LANCET (2002)
Where is the Meningitis Belt? Defining an area at risk of epidemic meningitis in Africa
AM Molesworth et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2002)
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story
E Miller et al.
VACCINE (2001)
Invasive meningococcal disease in adolescents and young adults
LH Harrison et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Immunization with recombinant opc outer membrane protein from Neisseria meningitidis:: Influence of sequence variation and levels of expression on the bactericidal immune response against meningococci
KA Jolley et al.
INFECTION AND IMMUNITY (2001)
Medical progress: Meningococcal disease.
NE Rosenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Serogroup W135 meningococcal disease in Hajj pilgrims
MK Taha et al.
LANCET (2000)
Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998
CT Sacchi et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine
SL Martin et al.
VACCINE (2000)
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
M Pizza et al.
SCIENCE (2000)
Lack of immunity in university students before an outbreak of serogroup C meningococcal infection
GR Jones et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: Implication for the composition of a recombinant TbpB-based vaccine
B Rokbi et al.
INFECTION AND IMMUNITY (2000)
分享论文
